Skip to content

AARD AARD Change in Other Assets

Change in Other Assets at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-$435K-326%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$340K+180%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$4.63M-148%
Arvinas logo
ArvinasARVN
$600K-77.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.92M+102%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's change in other assets?
AARD (AARD) reported change in other assets of $333K in Q1 2026.
How has AARD's change in other assets changed year-over-year?
AARD's change in other assets decreased by 92.4% year-over-year, from $4.36M to $333K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.